Search

Your search keyword '"Alexander Russell-Smith"' showing total 16 results

Search Constraints

Start Over You searched for: Author "Alexander Russell-Smith" Remove constraint Author: "Alexander Russell-Smith" Database OpenAIRE Remove constraint Database: OpenAIRE
16 results on '"Alexander Russell-Smith"'

Search Results

1. Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice

3. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures

4. Efficacy of non-intensive therapies approved for relapsed/refractory acute myeloid leukemia: a systematic literature review

5. Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK

6. The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review

9. The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review (Preprint)

10. Patterns of undertreatment among patients with acute myeloid leukemia (AML): considerations for patients eligible for non-intensive chemotherapy (NIC)

11. Characteristics of Medicare patients with relapsed/refractory acute lymphoblastic leukemia initiating treatment with inotuzumab ozogamicin, blinatumomab, or other agents

12. Patterns of Undertreatment Among Patients with Acute Myeloid Leukemia (AML) Not Receiving Standard Intensive Induction Chemotherapy

13. AML-243: Gemtuzumab Ozogamicin plus Standard Chemotherapy Carries a Comparable Burden of Hospitalization Compared with Standard Chemotherapy Alone in Acute Myeloid Leukemia

14. Preliminary Exploration of Patient Perspectives on Tyrosine Kinase Inhibitors for the Treatment of Chronic-Phase Chronic Myeloid Leukemia

15. Maintenance of Health-Related Quality of Life in the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase Chronic Myeloid Leukemia

16. Estimating the Relative Treatment Effect and Corresponding Cost-Effectiveness Estimates of Inotuzumab Ozogamicin Vs. Blinatumomab for Adults with Philadelphia Chromosome-Negative (Ph-) Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukaemia (B-ALL) in the United Kingdom (UK)

Catalog

Books, media, physical & digital resources